G
Glenmark Life Sciences Ltd
NSE:GLS
Glenmark Life Sciences Ltd
NSE:GLS
Price:
830.05 INR
1.07%
Market Closed
Updated:
May 16, 2024
Glenmark Life Sciences Ltd
Operating Expenses
|
Glenmark Life Sciences Ltd
Operating Expenses Peer Comparison
Comparables:
DRREDDY
CIPLA
SUNPHARMA
ZYDUSLIFE
T
TORNTPHARM
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
G
|
Glenmark Life Sciences Ltd
NSE:GLS
|
Operating Expenses
-₹6.6B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Operating Expenses
-₹133.4B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Operating Expenses
-₹117.1B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-10%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Operating Expenses
-₹267.7B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-16%
|
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Operating Expenses
-₹84.6B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-10%
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Operating Expenses
-₹53.5B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-11%
|
See Also
What is Glenmark Life Sciences Ltd's Operating Expenses?
Operating Expenses
-6.6B
INR
-6.6B
INR
Based on the financial report for Mar 31, 2024, Glenmark Life Sciences Ltd's Operating Expenses amounts to -6.6B INR.
What is Glenmark Life Sciences Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-17%
-17%
Over the last year, the Operating Expenses growth was -22%. The average annual Operating Expenses growth rates for Glenmark Life Sciences Ltd have been -17% over the past three years , -17% over the past five years .
You don't have any saved screeners yet
